Evaluation of effect of hybrid bioartificial liver using end-stage liver disease model

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 9

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

210

HTML

1452

Figures (1-1)

124

Tables (1-3)

102

Sum=1888

May 1, 2004 (publication date) through Apr 24, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. May 1, 2004; 10(9): 1379-1381
Published online May 1, 2004. doi: 10.3748/wjg.v10.i9.1379

Figure 1 Change of cytokines and LPS in different points.

Citation: Liu Q, Duan ZP, Huang C, Zhao CH. Evaluation of effect of hybrid bioartificial liver using end-stage liver disease model. World J Gastroenterol 2004; 10(9): 1379-1381
URL: https://www.wjgnet.com/1007-9327/full/v10/i9/1379.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i9.1379